Nan Fung Group Holdings’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Nan Fung Group Holdings’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-177,900	Closed	-$124K	–	49
2023 Q1	$124K	Hold	177,900	–	–	0.08%	39
2022 Q4	$160K	Hold	177,900	–	–	0.11%	36
2022 Q3	$1.07M	Buy	177,900 +35,000	+24%	+$198K	0.68%	20
2022 Q2	$592K	Hold	142,900	–	–	0.41%	24
2022 Q1	$543K	Hold	142,900	–	–	0.26%	30
2021 Q4	$643K	Hold	142,900	–	–	0.19%	32
2021 Q3	$666K	Buy	+142,900	New	+$757K	0.21%	24

Nan Fung Group Holdings's STSA Position: Q2 2023 in Review

Nan Fung Group Holdings sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 177,900 shares — an estimated $124K sold.

Nan Fung Group Holdings first reported a position in STSA in Q3 2021 and held it in 7 quarters. The position peaked at $1.07M in Q3 2022. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Nan Fung Group Holdings reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Nan Fung Group Holdings sold 177,900 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $124K.
Nan Fung Group Holdings first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Nan Fung Group Holdings's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $1.07M in Q3 2022.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Nan Fung Group Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.